BVF as of March 31, 2014
Portfolio Holdings for BVF
BVF holds 28 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals In (LGND) | 21.9 | $141M | 2.1M | 67.26 | |
| Ironwood Pharmaceuticals (IRWD) | 17.8 | $115M | 9.3M | 12.32 | |
| Chemocentryx | 8.0 | $52M | 7.8M | 6.63 | |
| Amgen (AMGN) | 7.0 | $45M | 365k | 123.34 | |
| Array BioPharma | 6.2 | $40M | 8.5M | 4.70 | |
| Oncomed Pharmaceuticals | 5.2 | $33M | 990k | 33.65 | |
| Exelixis Inc cnv | 4.9 | $31M | 35M | 0.90 | |
| Targacept | 4.5 | $29M | 6.2M | 4.75 | |
| Oncothyreon | 4.2 | $27M | 9.0M | 2.99 | |
| Five Prime Therapeutics | 3.5 | $22M | 1.1M | 19.66 | |
| Regado Biosciences | 3.2 | $21M | 1.7M | 12.52 | |
| Array Biopharma Inc note 3.000% 6/0 | 3.0 | $19M | 19M | 1.03 | |
| Receptos | 2.9 | $19M | 451k | 41.94 | |
| Qlt | 2.0 | $13M | 2.4M | 5.56 | |
| Rigel Pharmaceuticals | 1.6 | $10M | 2.6M | 3.88 | |
| ArQule | 0.8 | $5.0M | 2.4M | 2.05 | |
| Palatin Technologies | 0.5 | $3.5M | 2.8M | 1.23 | |
| Trevena | 0.4 | $2.8M | 350k | 7.86 | |
| Biota Pharmaceuticals | 0.4 | $2.7M | 436k | 6.11 | |
| Sophiris Bio | 0.3 | $2.0M | 600k | 3.33 | |
| Achaogen | 0.3 | $1.9M | 125k | 15.46 | |
| Anthera Pharmaceutcls | 0.3 | $1.9M | 560k | 3.35 | |
| Biolinerx Ltd-spons | 0.3 | $1.8M | 800k | 2.23 | |
| Regulus Therapeutics | 0.3 | $1.7M | 185k | 9.02 | |
| Mirati Therapeutics | 0.2 | $1.4M | 75k | 19.07 | |
| Bind Therapeutics | 0.2 | $1.4M | 116k | 11.96 | |
| Cytokinetics (CYTK) | 0.2 | $1.0M | 106k | 9.50 | |
| Transcept Pharmaceuticals | 0.1 | $462k | 150k | 3.08 |
